Vericel (VCEL) Operating Income (2010 - 2026)
Vericel's (VCEL) quarterly Operating Income came in at -$8.1 million in Q1 2026, up 36.96% year-on-year from -$5.9 million in Q1 2025, and down 135.98% quarter-over-quarter from $22.4 million in Q4 2025.
Vericel (VCEL) Operating Income (2010 - 2026) Analysis & Trends
Vericel has disclosed Operating Income across 17 years of filings, most recently posting -$8.1 million for Q1 2026.
- Operating Income for Q1 2026 came in at -$8.1 million, up 36.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.8 million (up 661.48% YoY), and the FY2025 annual result was $11.0 million, up 144.39% from the prior year.
- Operating Income came in at -$8.1 million for Q1 2026 at Vericel, down from $22.4 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $22.4 million in Q4 2025 to a low of -$12.8 million in Q1 2025.
- The 5-year median for Operating Income is -$5.5 million (2024), against an average of -$942529.4.
- Across the five-year window, Operating Income tumbled 143.55% in 2022 and jumped 239.96% in 2025, its largest moves.
- Vericel's Operating Income stood at $6.1 million in 2022, then soared by 109.22% to $12.7 million in 2023, then jumped by 45.15% to $18.5 million in 2024, then grew by 21.3% to $22.4 million in 2025, then tumbled by 135.98% to -$8.1 million in 2026.
- The last three Operating Income figures came in at -$8.1 million (Q1 2026), $22.4 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | -8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.06 Mn |
| Dec 31, 2025 | 22.42 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | -2.03 Mn |
| Mar 31, 2025 | -12.79 Mn |
| Dec 31, 2024 | 18.48 Mn |
| Sep 30, 2024 | -2.47 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Mar 31, 2024 | -5.46 Mn |
| Dec 31, 2023 | 12.73 Mn |
| Sep 30, 2023 | -5.06 Mn |
| Jun 30, 2023 | -5.96 Mn |
| Mar 31, 2023 | -8.18 Mn |
| Dec 31, 2022 | 6.09 Mn |
| Sep 30, 2022 | -6.79 Mn |
| Jun 30, 2022 | -9.08 Mn |
| Mar 31, 2022 | -7.27 Mn |
| Dec 31, 2021 | 4.14 Mn |
| Sep 30, 2021 | -4.96 Mn |
| Jun 30, 2021 | -3.73 Mn |